The historical rank and industry rank for Modern Chinese Medicine Group Co's EV-to-FCF or its related term are showing as below:
HKSE:01643'
s EV-to-FCF Range Over the Past 10 Years
Min: -36 Med: -0.54 Max: 13.5
Current: -23.39
During the past 7 years, the highest EV-to-FCF of Modern Chinese Medicine Group Co was 13.50. The lowest was -36.00. And the median was -0.54.
HKSE:01643's EV-to-FCF is ranked better than 99.81% of 530
companies
in the Drug Manufacturers industry
Industry Median: 22.78
vs HKSE:01643: -23.39
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Modern Chinese Medicine Group Co's EV-to-FCF
For the Drug Manufacturers - General subindustry, Modern Chinese Medicine Group Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Modern Chinese Medicine Group Co's EV-to-FCF Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Modern Chinese Medicine Group Co's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Modern Chinese Medicine Group Co's EV-to-FCF falls into.
Modern Chinese Medicine Group Co EV-to-FCF Calculation
Modern Chinese Medicine Group Co's current Enterprise Value is HK$-85.9 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Modern Chinese Medicine Group Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was HK$3.7 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Modern Chinese Medicine Group Co (HKSE:01643) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Modern Chinese Medicine Group Co's PE Ratio for today is calculated as:
Modern Chinese Medicine Group Co's share price for today is HK$0.375.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Modern Chinese Medicine Group Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.089.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Modern Chinese Medicine Group Co EV-to-FCF Related Terms
Thank you for viewing the detailed overview of Modern Chinese Medicine Group Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
Modern Chinese Medicine Group Co (HKSE:01643) Business Description
Modern Chinese Medicine Group Co Ltd is engaged in the production of proprietary Chinese medicine. It offers both OTC and prescribed medicines intended for use by the Middle-aged and the Elderly in the PRC. Its products include Vigour and Vitality Supplement Pill, Circulation Enhancement Pill, Cardiotonic Enhancement Capsule, Kidney Invigoration Pill, Heart Wellness Capsule, Menstrual Discomfort Relief Pill, Liver Detox Tablet, and Additional Ingredient Huoxiang ZhengQi Pill and Fever-removing and Detoxification Pill. The Group has one operating segment of its business as a whole as the production of PCM. Geographically, the majority is from PRC.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:01643 has been successfully added to your 